(lp0
S"Why ImmunoGen, Inc. Stock Jumped Higher Today Motley Fool - Apr 13, 2017 Investors interested in focusing on fundamentals should be paying attention to ImmunoGen's lead drug mirvetuximab soravtansine -- specifically a phase 1b/2 trial called FORWARD II testing the drug in combination with Avastin, carboplatin, Doxil, or ...ImmunoGen Inc.  Soars 9.46% on April 14 - Equities.comImmunoGen, Inc.  Rating Reiterated by Jefferies Group LLC - BNB Daily "
p1
aS'ImmunoGen, Inc.  Reports Recent Progress and Operating Results ... StockNewsUnion - 23 hours ago ImmunoGen, Inc.  has issued a review of some of its recent highlights in addition to announcing the financial results for the six-month period as well as the last quarter ended December 31, 2016.ImmunoGen, Inc. closed with a change of 9.46% in the Previous Trading Session - Free ObserverStock with Unusual Volume: ImmunoGen, Inc.  - StandardOracle'
p2
aS'The Technical Chart For ImmunoGen, Inc.  Is Very Revealing Today NY Stock News - 21 hours ago The technicals for ImmunoGen, Inc.  has spoken via its technical chart and the message is loud and clear. Based on that message, this is the relevant information necessary to make sense of that current setup.'
p3
aS"ImmunoGen's Mirva May Have Activity In FR High Ovarian Cancer Seeking Alpha - Mar 20, 2017 Immunogen  is a nanocap clinical stage biopharma developing Mirventuximab soravtansine, an antibody-drug conjugate  with a monoclonal antibody  that binds to FRalpha-positive tumor cells thereby delivering&nbsp;..."
p4
aS'ImmunoGen Inc.  Plunges 9.16% on April 05 Equities.com - Apr 5, 2017 ImmunoGen Inc.  had a rough trading day for Wednesday April 05 as shares tumbled 9.16%, or a loss of $-0.34 per share, to close at $3.37.Renaissance Technologies LLC Sells 21600 Shares of ImmunoGen, Inc.  - The Cerbat GemImmunoGen, Inc.  Closed the Last Trading Session with decrease of -9.16% - The Newburgh Press'
p5
aS'ImmunoGen Inc.  Plunges 6.17% on April 11 Equities.com - Apr 11, 2017 ImmunoGen Inc.  had a rough trading day for Tuesday April 11 as shares tumbled 6.17%, or a loss of $-0.19 per share, to close at $2.89.74 institutional investors are raising stakes in ImmunoGen, Inc.  - Post AnalystImmunoGen  Earning Very Positive Press Coverage, Study Finds - Markets Daily'
p6
aS'In Good Financial Health?  ImmunoGen, Inc. , Western Digital ... USA Commerce Daily - 22 hours ago Shares of ImmunoGen, Inc.  are making a strong comeback as they have jumped 114.57% since bottoming out at $1.51 on Nov. 03, 2016.'
p7
aS"What is the Short Interest on ImmunoGen, Inc.  Stock? Midway Monitor - 13 hours ago According to the latest stock data, investors are looking at ImmunoGen, Inc. 's short data and trying to figure out market sentiment on which way the market thinks the stock is moving."
p8
aS"Trading Statistics of ImmunoGen, Inc.  TRA - 20 hours ago ImmunoGen, Inc.  closed its previous trading session at $3.24 with the gain of 9.46%. The company's market cap is $293.9 Million, and the average volume is 1.74 Million."
p9
aS"Top Bull Stock Inside Thursday Spotlight: ImmunoGen, Inc.'s  stock price ... WsNews 4investors - 18 hours ago ImmunoGen, Inc.  stock price escalated 9.46% to finalize at $3.24 throughout previous buying and selling session."
p10
a.